Viswanathan Mohan News Today

India News: Particulate matter pollution could be triggering insulin resistance. Traffic jams are driving it to new levels. And pedestrians, the cleanest commute

If you keep on irritating the body by allowing all kinds of pollutants to get into it, the body cells are going to get irritated and cancer will come.

Pollution acts as an endocrine disruptor. When it acts as an endocrine disruptor it has an effect on the endocrine system of the human body and the effect on the pancreas is an important one. The way you get type two diabetes is due to two defects. One is the pancreas doesnt produce enough insulin. The other physiological defect is insulin resistance.

The rising prevalence of childhood obesity is slowly, but surely becoming a cause of serious public concern, with doctors the world over deeming it as a growing epidemic.

India is a ticking time bomb when it comes to non-communicable diseases, with over 100 million people with diabetes. India urgently needs a comprehensive, well-funded plan to deal with diabetes and NCDs.

An additional 136 million people nationwide also have prediabetes, a serious health condition marked by elevated blood sugar levels, among whom a large fraction are expected to advance into diabetes

New Delhi [India], February 17 (ANI/PRNewswire): Deakin University, Australia has recognised Subramanian Ramadorai for his distinguished lifetime achievement as a business leader, conferring upon him an honorary doctorate for his extensive contributions to the IT industry and his commitment to technological innovation for positive social outcomes.

A study reported that eating almonds daily for 12 weeks reduced insulin resistance, improved pancreatic function, and helped control blood glucose levels. What’s more, the almond treatment group achieved significant reductions in body weight, body mass index (BMI), and waist circumference over the intervention period and lowered their total cholesterol. The challenges of

In low- to middle-income countries, SGLT2 inhibitors could reduce diabetes complications at lower but feasible prices; they are cost effective at current prices in people with heart or kidney disease.